Literature DB >> 2809617

Early terminal and nodal sprouting of motor axons after botulinum toxin.

R Pamphlett1.   

Abstract

Axonal sprouting in distal motor axons was studied in an attempt to answer two questions: (a) is the cell body required for early axonal sprouting?, and (b) do nodal, as well as terminal, axonal sprouts arise after muscle inactivity not caused by nerve injury? Botulinum toxin (BT) was used to induce axonal sprouting without nerve trauma. Mice were injected in the right calf with a sublethal dose of BT and the soleus muscle examined ultrastructurally at times varying from 3 h to 5 days post-injection. Terminal axonal sprouts were seen 2 days after injection, and based on the time taken for BT to act and the growth rate of sprouts, axons were calculated to sprout within 24 h of muscle inactivity. This short time suggests that early axonal regrowth is initiated and controlled at the distal axon. Sprouts were seen arising from the intramuscular nodes of Ranvier from 2 days after BT injection. Unlike the terminal sprouts which elongated over time, the nodal sprouts remained short and confined by the basal lamina overlying the node, probably because without structural denervation there were no empty perineural sheaths to act as pathways to the motor endplates. The finding of terminal and nodal sprouts after botulinum toxin supports the hypothesis that muscle inactivity gives rise to a single growth factor for both terminal and nodal sprouting.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2809617     DOI: 10.1016/0022-510x(89)90135-4

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  16 in total

1.  Achalasia: outcome of patients treated with intrasphincteric injection of botulinum toxin.

Authors:  C Cuillière; P Ducrotté; F Zerbib; E H Metman; D de Looze; F Guillemot; H Hudziak; H Lamouliatte; J C Grimaud; A Ropert; M Dapoigny; R Bost; M Lémann; M A Bigard; P Denis; J L Auget; J P Galmiche; S Bruley des Varannes
Journal:  Gut       Date:  1997-07       Impact factor: 23.059

2.  Subcutaneous botulinum toxin type A inhibits regional sweating: an individual observation.

Authors:  W P Cheshire
Journal:  Clin Auton Res       Date:  1996-04       Impact factor: 4.435

Review 3.  Botulinum toxin. From poison to medicine.

Authors:  L E Davis
Journal:  West J Med       Date:  1993-01

4.  Secondary changes of the motor endplate in Lambert-Eaton myasthenic syndrome: a quantitative study.

Authors:  L F Hesselmans; F G Jennekens; J Kartman; J H Wokke; M de Visser; E G Klaver-Krol; M DeBaets; F Spaans; H Veldman
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

5.  Botulinum toxin treatment of extraocular muscles in rabbits results in increased myofiber remodeling.

Authors:  Irma Ugalde; Stephen P Christiansen; Linda K McLoon
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-11       Impact factor: 4.799

Review 6.  [Treatment of achalasia].

Authors:  Enrico P Cosentini; Etienne Wenzl; Raimund Jakesz
Journal:  Wien Klin Wochenschr       Date:  2004-05-31       Impact factor: 1.704

7.  Neuritogenic actions of botulinum neurotoxin A on cultured motor neurons.

Authors:  Julie A Coffield; Xiuzhen Yan
Journal:  J Pharmacol Exp Ther       Date:  2009-04-16       Impact factor: 4.030

Review 8.  The management of esophageal achalasia: from diagnosis to surgical treatment.

Authors:  Adrian Dobrowolsky; P Marco Fisichella
Journal:  Updates Surg       Date:  2013-07-02

9.  Myofiber length and three-dimensional localization of NMJs in normal and botulinum toxin treated adult extraocular muscles.

Authors:  Andrew R Harrison; Brian C Anderson; Ladora V Thompson; Linda K McLoon
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-08       Impact factor: 4.799

10.  Neurotrophic effects of Botulinum neurotoxin type A in hippocampal neurons involve activation of Rac1 by the non-catalytic heavy chain (HCC/A).

Authors:  Luis Solabre Valois; Vanilla Hua Shi; Paul Bishop; Bangfu Zhu; Yasuko Nakamura; Kevin A Wilkinson; Jeremy M Henley
Journal:  IBRO Neurosci Rep       Date:  2021-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.